- Home
- Publications
- Publication Search
- Publication Details
Title
Update on HIV/HCV Coinfection
Authors
Keywords
Hepatitis C, HIV, Coinfection, HIV/HCV coinfection, Sofosbuvir, Telaprevir, Boceprevir, Antiviral therapy
Journal
Current HIV/AIDS Reports
Volume 10, Issue 3, Pages 226-234
Publisher
Springer Nature
Online
2013-07-06
DOI
10.1007/s11904-013-0169-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Cost-Effectiveness of Birth-Cohort Screening for Hepatitis C Antibody in U.S. Primary Care Settings
- (2013) David B. Rein et al. ANNALS OF INTERNAL MEDICINE
- Genetic Determinants of Idiopathic Noncirrhotic Portal Hypertension in HIV-Infected Patients
- (2013) Eugenia Vispo et al. CLINICAL INFECTIOUS DISEASES
- 1417 SUSTAINED VIROLOGIC RESPONSE WITH DACLATASVIR PLUS SOFOSBUVIR ± RIBAVIRIN (RBV) IN CHRONIC HCV GENOTYPE (GT) 1-INFECTED PATIENTS WHO PREVIOUSLY FAILED TELAPREVIR (TVR) OR BOCEPREVIR (BOC)
- (2013) M.S. Sulkowski et al. JOURNAL OF HEPATOLOGY
- Breaking Down the Barriers to Hepatitis C Virus (HCV) Treatment Among Individuals With HCV/HIV Coinfection: Action Required at the System, Provider, and Patient Levels
- (2013) Jason Grebely et al. JOURNAL OF INFECTIOUS DISEASES
- Current Management of Hepatitis C Virus Infection in Patients With HIV Co-infection
- (2013) M. S. Sulkowski JOURNAL OF INFECTIOUS DISEASES
- Modeling shows that the NS5A inhibitor daclatasvir has two modes of action and yields a shorter estimate of the hepatitis C virus half-life
- (2013) J. Guedj et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Hepatitis C virus viremia increases the incidence of chronic kidney disease in HIV-infected patients
- (2012) Lars Peters et al. AIDS
- Low risk of liver toxicity using the most recently approved antiretroviral agents but still increased in HIV–hepatitis C virus coinfected patients
- (2012) Eugenia Vispo et al. AIDS
- The changing face of hepatitis C in the new era of direct-acting antivirals
- (2012) Vincent Soriano et al. ANTIVIRAL RESEARCH
- Lack of a Clinically Significant Drug–Drug Interaction in Healthy Volunteers Between the Hepatitis C Virus Protease Inhibitor Boceprevir and the HIV Integrase Inhibitor Raltegravir
- (2012) Clara T. M. M. de Kanter et al. CLINICAL INFECTIOUS DISEASES
- Pharmacokinetic Interactions Between the Hepatitis C Virus Protease Inhibitor Boceprevir and Ritonavir-Boosted HIV-1 Protease Inhibitors Atazanavir, Darunavir, and Lopinavir
- (2012) Ellen G. J. Hulskotte et al. CLINICAL INFECTIOUS DISEASES
- Expanding Access to Treatment for Hepatitis C in Resource-Limited Settings: Lessons From HIV/AIDS
- (2012) N. Ford et al. CLINICAL INFECTIOUS DISEASES
- Pharmacokinetics of new oral hepatitis C antiviral drugs
- (2012) Eugenia Vispo et al. Expert Opinion on Drug Metabolism & Toxicology
- Management of Patients Coinfected With HCV and HIV: A Close Look at the Role for Direct-Acting Antivirals
- (2012) Susanna Naggie et al. GASTROENTEROLOGY
- HIV and viral hepatitis coinfections: advances and challenges
- (2012) Karine Lacombe et al. GUT
- Treatment of Hepatitis C in Patients Infected with Human Immunodeficiency Virus in the Direct-Acting Antiviral Era
- (2012) Vincent Soriano et al. INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
- Pharmacokinetic Interaction Between Boceprevir and Etravirine in HIV/HCV Seronegative Volunteers
- (2012) Kyle P. Hammond et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Relationship of Liver Disease Stage and Antiviral Therapy With Liver-Related Events and Death in Adults Coinfected With HIV/HCV
- (2012) Berkeley N. Limketkai et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Antiretroviral Treatment of Adult HIV Infection
- (2012) Melanie A. Thompson et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Different impact of IL28B polymorphisms on response to peginterferon-α plus ribavirin in HIV-positive patients infected with HCV subtypes 1a or 1b
- (2012) Eugenia Vispo et al. JOURNAL OF CLINICAL VIROLOGY
- Chronic Hepatitis C Virus Infection Increases Mortality From Hepatic and Extrahepatic Diseases: A Community-Based Long-Term Prospective Study
- (2012) M.-H. Lee et al. JOURNAL OF INFECTIOUS DISEASES
- Preliminary Study of Two Antiviral Agents for Hepatitis C Genotype 1
- (2012) Anna S. Lok et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Burden of Liver Disease in Human Immunodeficiency Virus-Infected Patients
- (2012) Massimo Puoti et al. SEMINARS IN LIVER DISEASE
- Management and Treatment of Chronic Hepatitis C in HIV Patients
- (2012) Pablo Barreiro et al. SEMINARS IN LIVER DISEASE
- Challenges and Priorities in the Management of HIV/HBV and HIV/HCV Coinfection in Resource-Limited Settings
- (2012) Philippa Easterbrook et al. SEMINARS IN LIVER DISEASE
- Liver Toxicity of Antiretroviral Drugs
- (2012) Michelle Jones et al. SEMINARS IN LIVER DISEASE
- Acute Hepatitis C in Patients with HIV
- (2012) Christoph Boesecke et al. SEMINARS IN LIVER DISEASE
- Russia and human immunodeficiency virus-beyond crime and punishment
- (2011) JEFFREY H. SAMET ADDICTION
- Challenges and opportunities for hepatitis C drug development in HIV–hepatitis C virus-co-infected patients
- (2011) Vincent Soriano et al. AIDS
- The hepatitis C epidemic among HIV-positive MSM: incidence estimates from 1990 to 2007
- (2011) Jannie J van der Helm et al. AIDS
- Alarming incidence of hepatitis C virus re-infection after treatment of sexually acquired acute hepatitis C virus infection in HIV-infected MSM
- (2011) Femke A.E. Lambers et al. AIDS
- Predicted effect of direct acting antivirals in the current HIV–HCV-coinfected population in Spain
- (2011) Eva Poveda et al. ANTIVIRAL THERAPY
- Safety and efficacy of raltegravir in patients with HIV-1 and hepatitis B and/or C virus coinfection
- (2011) JK Rockstroh et al. HIV MEDICINE
- Association of a single nucleotide polymorphism near the interleukin-28B gene with response to hepatitis C therapy in HIV/hepatitis C virus-coinfected patients
- (2010) Norma I Rallón et al. AIDS
- Modeling the Probability of Sustained Virological Response to Therapy with Pegylated Interferon plus Ribavirin in Patients Coinfected with Hepatitis C Virus and HIV
- (2010) Jose Medrano et al. CLINICAL INFECTIOUS DISEASES
- Noncirrhotic portal hypertension in HIV infection
- (2010) Eugenia Vispo et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Changes in liver stiffness in patients with chronic hepatitis C with and without HIV co-infection treated with pegylated interferon plus ribavirin
- (2010) J. Macias et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Antiretroviral drugs and liver injury
- (2009) Vincent Soriano et al. AIDS
- Evaluation of the role of three candidate human kinases in the conversion of the hepatitis C virus inhibitor 2′-C-methyl-cytidine to its 5′-monophosphate metabolite
- (2009) Nina L. Golitsina et al. ANTIVIRAL RESEARCH
- Association of Noncirrhotic Portal Hypertension in HIV‐Infected Persons and Antiretroviral Therapy with Didanosine: A Nested Case‐Control Study
- (2009) Helen Kovari et al. CLINICAL INFECTIOUS DISEASES
- Decrease in Serial Prevalence of Coinfection with Hepatitis C Virus among HIV‐Infected Patients in Spain, 1997–2006
- (2009) Santiago Pérez Cachafeiro et al. CLINICAL INFECTIOUS DISEASES
- Sustained virological response to interferon plus ribavirin reduces liver-related complications and mortality in patients coinfected with human immunodeficiency virus and hepatitis C virus
- (2009) Juan Berenguer et al. HEPATOLOGY
- Upper Gastrointestinal Bleeding May Unmask Didanosine-Associated Portal Hepatopathy in HIV/HCV Co-infected Patients
- (2009) Eugenia Vispo et al. HIV CLINICAL TRIALS
- Hepatic safety profile of raltegravir in HIV-infected patients with chronic hepatitis C
- (2009) E. Vispo et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Comparison of transient elastography and liver biopsy for the assessment of liver fibrosis in HIV/hepatitis C virus-coinfected patients and correlation with noninvasive serum markers
- (2009) M. Sánchez-Conde et al. JOURNAL OF VIRAL HEPATITIS
- The risk of transfusion-transmitted infections in sub-Saharan Africa
- (2009) Sudha Jayaraman et al. TRANSFUSION
- Why are there different dynamics in the selection of drug resistance in HIV and hepatitis B and C viruses?
- (2008) V. Soriano et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started